Andreas Halvorsen Viking Global Investors
Andreas Halvorsen is the founder of Viking Global Investors, another prominent firm with roots in Julian Robertson’s Tiger Management. Viking is known for fundamental long/short equity investing and a large, research-intensive platform. Its public filings are widely monitored for institutional-quality growth and cyclical equity ideas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Express
AXP
|
+$609M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$581M |
| 3 |
Hilton Worldwide
HLT
|
+$540M |
| 4 |
Comcast
CMCSA
|
+$404M |
| 5 |
Fidelity National Information Services
FIS
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$980M |
| 2 |
Amazon
AMZN
|
+$645M |
| 3 |
JD.com
JD
|
+$536M |
| 4 |
Boston Scientific
BSX
|
+$481M |
| 5 |
Lowe's Companies
LOW
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.56% |
| 2 | Consumer Discretionary | 19.72% |
| 3 | Technology | 19.48% |
| 4 | Financials | 14.6% |
| 5 | Communication Services | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Cooper Companies
COO
$14.9B
| $98M | 0.42% |
1,382,092
-365,852
| -21% | -$27.1M |
|
52
Envista
NVST
$4.37B
| $95.4M | 0.41% |
+4,524,346
| New | +$84.8M |
|
53
Avantor
AVTR
$9.78B
| $93.1M | 0.4% |
5,475,379
-4,575,459
| -46% | -$74.5M |
|
54
Everest Group
EG
$14.2B
| $86.2M | 0.37% |
+418,223
| New | +$81.4M |
|
|
HZNP
55
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $81.8M | 0.35% |
1,471,419
-519,851
| -26% | -$22.2M |
|
56
CME Group
CME
$98.9B
| $78.5M | 0.34% |
482,679
-1,219,294
| -72% | -$219M |
|
57
TJX Companies
TJX
$155B
| $76.8M | 0.33% |
+1,519,986
| New | +$76.3M |
|
58
PVH
PVH
$3.62B
| $73.2M | 0.32% |
+1,522,984
| New | +$71M |
|
59
Mercado Libre
MELI
$97.5B
| $68.4M | 0.3% |
69,344
-319,941
| -82% | -$240M |
|
|
BMY.RT
60
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $67.9M | 0.29% |
18,968,019
-671,182
| -3% | -$2.42M |
|
61
Liberty Media Series C
FWONK
$26.3B
| $61M | 0.26% |
1,989,456
| – | – |
|
|
CHNG
62
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $48.5M | 0.21% |
4,326,999
-8,450,240
| -66% | -$94.9M |
|
|
VIE
63
DELISTED
Viela Bio, Inc. Common Stock
VIE
| $45.4M | 0.2% |
1,049,000
-201,000
| -16% | -$9.1M |
|
|
VAR
64
DELISTED
Varian Medical Systems, Inc.
VAR
| $44.8M | 0.19% |
365,827
-501,283
| -58% | -$58.1M |
|
65
Visa
V
$693B
| $31.9M | 0.14% |
164,889
-265,220
| -62% | -$48.5M |
|
|
MNTA
66
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $31.5M | 0.14% |
+946,220
| New | +$30.1M |
|
67
Genmab
GMAB
$20.6B
| $19.5M | 0.08% |
575,086
-265,899
| -32% | -$7.25M |
|
|
API
68
Agora
API
$369M
| $17.7M | 0.08% |
+400,000
| New | +$18.9M |
|
69
Editas Medicine
EDIT
$478M
| $12.2M | 0.05% |
413,000
-99,179
| -19% | -$2.59M |
|
70
uniQure
QURE
$3.36B
| $2.81M | 0.01% |
+62,396
| New | +$3.68M |
|
|
ATYR
71
aTyr Pharma
ATYR
$49.2M
| $2.61M | 0.01% |
587,444
| – | – |
|
|
TMUSR
72
DELISTED
T-Mobile US, Inc. Subscription Rights Expiring 7/27/2020
TMUSR
| $302K | ﹤0.01% |
+1,799,550
| New | +$505K |
|
73
Agilent Technologies
A
$44.9B
| – | – |
-2,789,478
| Closed | -$200M |
|
74
Arthur J. Gallagher & Co
AJG
$67.6B
| – | – |
-1,158,751
| Closed | -$94.5M |
|
75
BioMarin Pharmaceuticals
BMRN
$12.9B
| – | – |
-1,453,625
| Closed | -$123M |
|
Similar funds
Andreas Halvorsen's Q2 2020 Portfolio in Review
As of Q2 2020, Andreas Halvorsen held 88 positions worth $23.1B, up 20% from $19.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Andreas Halvorsen's Q2 2020 filing shows 24 new, 15 increased, 29 reduced and 16 closed positions. Its largest new stake was Thermo Fisher Scientific: 1,734,144 shares worth $628M. The largest sale was Netflix, an estimated $980M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Technology.
- Andreas Halvorsen's largest Q2 2020 buy was Thermo Fisher Scientific: 1,734,144 shares worth $628M.
- Andreas Halvorsen added most to American Express in Q2 2020, an estimated $609M increase.
- Andreas Halvorsen's biggest Q2 2020 reduction was Netflix, cutting an estimated $980M.
- Andreas Halvorsen fully exited Elevance Health in Q2 2020, selling an estimated $411M.
- Andreas Halvorsen's ten largest holdings make up 44% of its $23.1B portfolio in Q2 2020.
- Andreas Halvorsen opened 24 new positions and closed 16 in Q2 2020.
- Andreas Halvorsen's portfolio value rose 20% quarter-over-quarter to $23.1B.
Based on Viking Global Investors's 13F filing for Q2 2020, filed 7 Aug 2020.